Norg Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 8 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 1080.36%
(FY 2022)
- Profit 333.72%
(FY 2022)
- Ebitda 327.97%
(FY 2022)
- Net Worth 77.72%
(FY 2022)
- Total Assets 1.86%
(FY 2022)
About Norg Biotech
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jeetendra Sevawat, Prerna Madhok, Raghvendra Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U01400DL2017PTC310028
- Company No.
310028
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Norg Biotech Private Limited offer?
Norg Biotech Private Limited offers a wide range of products and services, including Eye Drops, Moxifloxacin Eye Drop, Fertilizer, Water Soluble Fertilizers, Organic Fertilizers and Manure, Common Disease Medicines, Fertilizers and Soil Additives, Bio Fertilizers, Rhizobium Biofertilizer, Vermicompost.
Who are the key members and board of directors at Norg Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghvendra Singh  | Additional Director | 27-Jan-2017 | Current |
| Jeetendra Sevawat | Director | 02-Jan-2017 | Current |
| Prerna Madhok | Director | 02-Jan-2017 | Current |
| Sunita Madhok | Director | 23-Feb-2022 | Current |
Financial Performance of Norg Biotech.
Norg Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1080.36% increase. The company also saw a substantial improvement in profitability, with a 333.72% increase in profit. The company's net worth Soared by an impressive increase of 77.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Norg Biotech?
Unlock access to Norg Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Cofarmin Federation Of Producer OrganizationsActive 3 years 2 months
Jeetendra Sevawat and Raghvendra Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Norg Biotech?
Unlock and access historical data on people associated with Norg Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Norg Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norg Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
